CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Oral dietary supplements (563 kcal/d), RESPIFOR +3 moredrug
Likely dose
160 mg/d of oral testosterone undecanoate in men, 80 mg/d in womenfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00230984
NCT00230984Phase 3Completed

Effects of Home Pulmonary Rehabilitation in Patients With Chronic Respiratory Failure and Nutritional Depletion.

University Hospital, Grenoble·interventional·Posted Oct 3, 2005·Updated Jul 8, 2009

In Brief

A Phase 3 clinical trial evaluating education, Oral dietary supplements (563 kcal/d), RESPIFOR, and 2 other interventions for Chronic Respiratory Failure and Nutritional Depletion. Completed, across 8 sites in 2 countries.

Detailed Summary

Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion. This is a randomized controlled, open clinical trial with two groups. * first group, 100 patients : control group, patients followed with no add-on intervention * Second group, 100 patients : rehabilitation group with education, oral supplements, exercise and androgenic steroids.

Study Details

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 3, 2005
Enrollment StartApr 1, 2003
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 20.7 years ago

Interventions

educationbehavioral

Oral dietary supplements (563 kcal/d), RESPIFORdrug

exercises on an ergometric bicycle 3 to 5 times a weekbehavioral

160 mg/d of oral testosterone undecanoate in men, 80 mg/d in womendrug